[Effect of an immunological therapeutic agent on the development of an experimental gingivitis in man].
D000328:Adult; D000942:Antigens, Bacterial / Q000627:therapeutic use*; D000946:Antigens, Fungal / Q000627:therapeutic use*; D003773:Dental Plaque / Q000032:analysis / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D004338:Drug Combinations / Q000627:therapeutic use; D005035:Ethylmercury Compounds / Q000627:therapeutic use*; D005260:Female; D005891:Gingivitis / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D013849:Thimerosal / Q000627:therapeutic use*
D000942:Antigens, Bacterial; D000946:Antigens, Fungal; D004338:Drug Combinations; D005035:Ethylmercury Compounds; C011874:imudon; D013849:Thimerosal
Action d'une thérapeutique immunologique sur le développement d'une gingivite expérimentale chez l'homme.